HealthDay.com
Lasting Outcomes for Imatinib in Chronic Myeloid Leukemia
Estimated overall survival 83.3 percent at 10 years for patients in imatinib treatment group
Retinal Microvascular Findings Linked to Risk of PAD
Retinal hemorrhages, exudates, microaneurysms, retinopathy linked to risk of peripheral artery disease
American Academy of Dermatology, March 3-7
The American Academy of Dermatology The annual meeting of the American Academy of Dermatology was held from March 3 to 7 in Orlando,...
Lack of Fruits, Vegetables Ups Global Heart Disease Burden
New analysis finds low consumption linked to more lost years of healthy life
Off-Label Donepezil Rx for MCI Could Be Risky for Some Patients
Medication has detrimental effect on patients with the K-variant of the butyrylcholinesterase gene
American Academy of Allergy, Asthma & Immunology, March 3-6
The American Academy of Allergy, Asthma & Immunology The annual meeting of the American Academy of Allergy, Asthma & Immunology was held from...
Rates of Hepatitis C Testing Too Low in Baby Boomers
Screening rates remain low despite recommendations, researchers say
Ketamine Beneficial for Certain Patients With Mood Disorders
Available data on ketamine use are limited and risks should be considered before its use
Family Medicine Faculty More Diverse Than Others
However, women and minorities still hold a higher percentage of lower-ranking faculty positions
CDC: Arthritis Limits the Activities of 24 Million U.S. Adults
One in four adults have been diagnosed with arthritis in the United States
